165 related articles for article (PubMed ID: 15057158)
21. Combined modality treatment with primary CHOP chemotherapy followed by locoregional irradiation in stage I or II histologically aggressive non-Hodgkin's lymphomas.
Tondini C; Zanini M; Lombardi F; Bengala C; Rocca A; Giardini R; Buzzoni R; Valagussa P; Bonadonna G
J Clin Oncol; 1993 Apr; 11(4):720-5. PubMed ID: 8478665
[TBL] [Abstract][Full Text] [Related]
22. Treatment for non-Hodgkin's lymphoma (stage I, II) of the elderly: usefulness of local and regional irradiation and reduced dose chemotherapy.
Oguchi M; Izuno I; Takei K; Shikama N; Sasaki S; Gomi K; Sone S
Int J Radiat Oncol Biol Phys; 1997 Jan; 37(1):87-92. PubMed ID: 9054881
[TBL] [Abstract][Full Text] [Related]
23. Results of radiotherapy and combined modality treatment in early stage high grade non-Hodgkin's lymphoma.
Frank C; Flentje M; Goldschmidt H; Hunstein W; Wannenmacher M
Strahlenther Onkol; 1994 Jul; 170(7):383-90. PubMed ID: 8052937
[TBL] [Abstract][Full Text] [Related]
24. [Chemoradiation treatment of patients with aggressive non-Hodgkin's lymphomas in stages I to II of the disease].
Sotnikov VM; Polianskaia AM; Pan'shin GA; Ingberman IaKh; Kaplanskaia IB
Ter Arkh; 1989; 61(7):20-3. PubMed ID: 2588136
[TBL] [Abstract][Full Text] [Related]
25. Stage I non-Hodgkin's lymphoma treated with doxorubicin-containing chemotherapy with or without radiotherapy.
Villikka K; Muhonen T; Ristamäki R; Teerenhovi L; Joensuu H
Acta Oncol; 1997; 36(6):619-24. PubMed ID: 9408153
[TBL] [Abstract][Full Text] [Related]
26. Intensive sequential chemotherapy with repeated blood stem-cell support for untreated poor-prognosis non-Hodgkin's lymphoma.
Stoppa AM; Bouabdallah R; Chabannon C; Novakovitch G; Vey N; Camerlo J; Blaise D; Xerri L; Resbeut M; Di Stefano D; Bardou VJ; Gastaut JA; Maraninchi D
J Clin Oncol; 1997 May; 15(5):1722-9. PubMed ID: 9164178
[TBL] [Abstract][Full Text] [Related]
27. Improved survival rate in primary intracranial lymphoma treated by high-dose radiation and systemic vincristine-doxorubicin-cyclophosphamide-prednisolone chemotherapy.
Shibamoto Y; Tsutsui K; Dodo Y; Yamabe H; Shima N; Abe M
Cancer; 1990 May; 65(9):1907-12. PubMed ID: 2372761
[TBL] [Abstract][Full Text] [Related]
28. Thyroid lymphoma. The case for combined modality therapy.
Doria R; Jekel JF; Cooper DL
Cancer; 1994 Jan; 73(1):200-6. PubMed ID: 8275426
[TBL] [Abstract][Full Text] [Related]
29. Diagnosis and treatment of malignant lymphoma of the parotid gland.
Hirokawa N; Hareyama M; Akiba H; Satoh M; Oouchi A; Tamakawa M; Sakata K; Nagakura H; Koito K; Morita K; Harabuchi Y; Kataura A; Hinoda Y
Jpn J Clin Oncol; 1998 Apr; 28(4):245-9. PubMed ID: 9657009
[TBL] [Abstract][Full Text] [Related]
30. Treatment of localized non-Hodgkin's lymphomas of the head and neck.
Ruijs CD; Dekker AW; van Kempen-Harteveld ML; van Baarlen J; Hordijk GJ
Cancer; 1994 Jul; 74(2):703-7. PubMed ID: 8033051
[TBL] [Abstract][Full Text] [Related]
31. Treatment and prognosis of orbital non-Hodgkin's lymphomas.
Platanias LC; Putterman AM; Vijayakumar S; Recant W; Weichselbaum RR; Bitran JD
Am J Clin Oncol; 1992 Feb; 15(1):79-83. PubMed ID: 1372464
[TBL] [Abstract][Full Text] [Related]
32. [The radiation and chemoradiation treatments of generalized low-grade non-Hodgkin's lymphomas. 1. The immediate results].
Sotnikov VM; Kharchenko VP; Pan'shin GA; Galil-Ogly GA; Zhdanov GP; Zakharova LV; Teĭblium MM; Tolchinskiĭ BI
Vestn Rentgenol Radiol; 1996; (2):26-9. PubMed ID: 8754118
[TBL] [Abstract][Full Text] [Related]
33. Radiation therapy for consolidation of metastatic or recurrent sarcomas in children treated with intensive chemotherapy and stem cell rescue. A feasibility study.
Czyzewski EA; Goldman S; Mundt AJ; Nachman J; Rubin C; Hallahan DE
Int J Radiat Oncol Biol Phys; 1999 Jun; 44(3):569-77. PubMed ID: 10348286
[TBL] [Abstract][Full Text] [Related]
34. Operative and conservative management of primary gastric lymphoma: interim results of a German multicenter study.
Willich NA; Reinartz G; Horst EJ; Delker G; Reers B; Hiddemann W; Tiemann M; Parwaresch R; Grothaus-Pinke B; Kocik J; Koch P
Int J Radiat Oncol Biol Phys; 2000 Mar; 46(4):895-901. PubMed ID: 10705011
[TBL] [Abstract][Full Text] [Related]
35. [Statistical analysis of localized non-Hodgkin's lymphomas of the head and neck--multivariate analysis of prognostic factors and evaluation of therapeutic modalities].
Tomita T; Fujii M; Imanishi Y; Kanke M; Kanzaki J; Ohno Y; Tokumaru Y; Inuyama Y
Nihon Jibiinkoka Gakkai Kaiho; 1999 Jun; 102(6):809-17. PubMed ID: 10429435
[TBL] [Abstract][Full Text] [Related]
36. [Clinical analysis of 82 patients with non-Hodgkin's lymphoma--mainly on the evaluation of therapeutic efficacy].
Kakinoki Y; Maekawa I; Kawamura T; Miyake T; Kurosawa M; Okabe M; Kamiya K; Sasaki O
Hokkaido Igaku Zasshi; 1987 Dec; 62(6):841-50. PubMed ID: 3443427
[TBL] [Abstract][Full Text] [Related]
37. Combination chemotherapy as single modality therapy for stage IE and IIE thyroid lymphoma.
Leedman PJ; Sheridan WP; Downey WF; Fox RM; Martin FI
Med J Aust; 1990 Jan; 152(1):40-3. PubMed ID: 2403625
[TBL] [Abstract][Full Text] [Related]
38. Combined modality treatment for stage I-II non-Hodgkin's lymphomas: CVP versus BACOP chemotherapy.
Bajetta E; Valagussa P; Bonadonna G; Lattuada A; Buzzoni R; Rilke F; Banfi A
Int J Radiat Oncol Biol Phys; 1988 Jul; 15(1):3-12. PubMed ID: 2455701
[TBL] [Abstract][Full Text] [Related]
39. Aggressive lymphomas with renal involvement: a study of 48 patients treated with the LNH-84 and LNH-87 regimens. Groupe d'Etude des Lymphomes de l'Adulte.
Morel P; Dupriez B; Herbrecht R; Bastion Y; Tilly H; Delannoy A; Haioun C; Nouvel C; Bouabdallah K; Baumelou E
Br J Cancer; 1994 Jul; 70(1):154-9. PubMed ID: 7517172
[TBL] [Abstract][Full Text] [Related]
40. Intermediate-grade lymphomas treated with cyclophosphamide-doxorubicin- vincristine-prednisone-bleomycin alternated with cyclophosphamide-methotrexate-etoposide-dexamethasone. Application of prognostic models to data analysis.
Velasquez WS; McLaughlin P; Fuller LM; Allen PK; Tucker SL; Swan F; Rodriguez MA; Hagemeister FB; Cabanillas FF
Cancer; 1994 May; 73(9):2408-16. PubMed ID: 7513251
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
